(Q44740259)

5 December 2017

title

Pharmacodynamics of meropenem and imipenem against Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa (English)

1 reference

5 December 2017

main subject

Acinetobacter baumannii

1 reference

1 reference

0 references

Pseudomonas aeruginosa

1 reference

1 reference

1

Joseph L Kuti

1 reference

5 December 2017

4

David P Nicolau

1 reference

5 December 2017

Naomi R Florea

2

1 reference

5 December 2017

Charles H Nightingale

series ordinal

3

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

5 December 2017

1 reference

5 December 2017

volume

24

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

8-15

1 reference

Of Pseudomonas, porins, pumps and carbapenems.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.8.34804

Antimicrobial resistance trends in medical centers using carbapenems: report of 1999 and 2000 results from the MYSTIC program (USA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.8.34804

Detection of emerging resistance patterns within longitudinal surveillance systems: data sensitivity and microbial susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.8.34804

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.8.34804

Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.8.34804

Worldwide antimicrobial susceptibility patterns and pharmacodynamic comparisons of gatifloxacin and levofloxacin against Streptococcus pneumoniae: report from the Antimicrobial Resistance Rate Epidemiology Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.8.34804

Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.8.34804

Comparative pharmacokinetics of the carbapenems: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.8.34804

In vitro activity and pharmacodynamics of azithromycin and clarithromycin against Streptococcus pneumoniae based on serum and intrapulmonary pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.8.34804

Pharmacodynamics of cefepime in patients with Gram-negative infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.8.34804

Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.8.34804

Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.8.34804

A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.8.34804

Pharmacokinetics and pharmacodynamics of meropenem in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.8.34804

Pharmacokinetic and pharmacodynamic evaluation of two dosing regimens for piperacillin-tazobactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.8.34804

Phenotypic antimicrobial resistance patterns in Pseudomonas aeruginosa and Acinetobacter: results of a Multicenter Intensive Care Unit Surveillance Study, 1995-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.8.34804

Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.8.34804

10.1592/PHCO.24.1.8.34804

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference